Alyeska Investment Group
CGON icon

Alyeska Investment Group’s CG Oncology CGON Stock Holding History

Alyeska Investment Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-150,000
Closed -$3.9M – 606
2025
Q2 		$3.9M Buy
+150,000
New +$3.61M 0.01% 440
2025
Q1 		– Sell
-45,000
Closed -$1.29M – 528
2024
Q4 		$1.29M Buy
+45,000
New +$1.54M ﹤0.01% 488

Other funds holding CGON

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Alyeska Investment Group's CGON Position: Q3 2025 in Review

Alyeska Investment Group sold out of CG Oncology (CGON) in Q3 2025, closing a stake of 150,000 shares — an estimated $3.9M sold.

Alyeska Investment Group first reported a position in CGON in Q4 2024 and held it in 2 quarters. The position peaked at $3.9M in Q2 2025. 176 funds tracked by Wall St. Rank hold CGON as of Q3 2025.

  • Alyeska Investment Group reported no remaining CG Oncology position as of Q3 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 150,000 CG Oncology shares in Q3 2025, an estimated $3.9M.
  • Alyeska Investment Group first reported a position in CG Oncology in Q4 2024 and held it in 2 quarters.
  • Alyeska Investment Group's CG Oncology position peaked at $3.9M in Q2 2025.
  • 176 funds tracked by Wall St. Rank held CG Oncology as of Q3 2025.

Based on Alyeska Investment Group's 13F filing for Q3 2025, filed 17 Nov 2025.